Skye Bioscience, Inc.

SKYE

Skye Bioscience, Inc.

SKYE

Insider Sentiment (TTM):

Last Purchase:2024-03-13Last Sale:2025-08-22Shares Purchased (TTM):0Shares Sold (TTM):0

Institutional Sentiment:

As of:2026-03-31Institutional Shares Owned:16,129,853Shares Outstanding:39,681,465Institutional Ownership Pct.:40.65%

Earnings Market Reaction:

Filing Date:2026-08-14Price on Filing Date:N/APrevious Close:N/A% Change:N/A

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Financial Statements

10‑Q10‑K

Values in Millions ($)	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Assets
Nonrelated Party	-	-	-	-	-	-	1	-	-	-	1	-
Related Party	-	-	-	-	-	-	1	-	-	-	1	-
Assets Current
Cash And Cash Equivalents At Carrying Value	8	8	6	18	24	46	68	67	74	83	1	5
Cash	-	-	-	-	-	-	-	-	-	-	1	-
Short Term Investments	2	9	20	17	25	13	0	-	-	-	-	-
Prepaid Expense Current	0	1	1	4	1	1	0	1	1	1	0	0
Other Assets Current	0	0	1	1	1	3	2	3	3	2	1	1
Assets Of Disposal Group Including Discontinued Op…	-	-	-	-	-	-	-	-	-	-	0	0
Restricted Cash And Cash Equivalents At Carrying V…	-	-	-	-	-	-	0	9	9	9	9	9
Assets Current	11	19	27	40	51	63	71	80	87	95	12	15
Property Plant And Equipment Net	0	1	1	1	1	1	1	2	0	0	0	0
Operating Lease Right Of Use Asset	0	0	0	0	0	0	0	0	0	0	0	0
Other Assets Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Assets	11	19	28	41	52	65	73	82	87	95	12	16
Liabilities And Stockhold…
Liabilities Current
Accounts Payable Current	4	4	2	3	3	2	1	1	1	1	-	2
Accounts Payable Related Parties Current	-	-	-	-	-	-	-	-	-	-	-	0
Employee Related Liabilities Current	1	0	1	1	1	1	1	1	1	0	1	1
Interest Payable Current	-	-	-	-	-	-	-	0	0	0	-	-
Other Liabilities Current	1	3	3	2	2	1	1	2	1	3	-	1
Due To Other Related Parties Classified Current	-	-	-	-	-	-	-	-	-	-	-	0
Loss Contingency Accrual Carrying Value Current	5	3	2	2	2	2	2	2	6	6	6	6
Loans Payable Current	0	0	-	-	-	-	-	-	-	-	-	0
Operating Lease Liability Current	0	0	0	0	0	0	0	0	0	0	0	0
Liabilities Current	12	10	8	8	8	5	4	6	14	16	14	14
Liabilities Noncurrent
Operating Lease Liability Noncurrent	0	0	0	0	0	0	0	0	0	0	0	0
Convertible Debt Current	-	-	-	-	-	-	0	0	5	5	4	4
Other Long Term Debt Current	-	-	-	-	-	-	-	-	-	-	0	-
Liabilities	12	10	8	8	8	6	5	6	14	16	14	14
Stockholders Equity
Preferred Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Value	0	0	0	0	0	0	0	0	0	0	0	0
Additional Paid In Capital Common Stock	210	208	207	205	203	201	199	197	190	188	102	102
Retained Earnings Accumulated Deficit	-210	-199	-187	-172	-160	-142	-131	-121	-117	-109	-104	-100
Stockholders Equity	-0	9	20	33	44	59	68	76	73	79	-2	2
Liabilities And Stockholders Equity	11	19	28	41	52	65	73	82	87	95	12	16
Preferred Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0	0.001
Preferred Stock Shares Authorized	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Issued	0	0	0	0	0	0	0	0	0	0	0	0
Preferred Stock Shares Outstanding	0	0	0	0	0	0	0	0	0	0	0	0
Common Stock Par Or Stated Value Per Share	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001	0.001
Common Stock Shares Authorized	300	100	100	100	100	100	100	100	100	100	100	100
Common Stock Shares Issued	35	35	33	31	31	31	31	30	28	28	12	12
Shares Outstanding	35	35	33	31	31	31	31	30	28	28	12	12

Subscribe to unlock 17+ years of financial data, unlimited metrics, and saved tables

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, and saved tables

Start free trial

Custom Table

10‑Q10‑K

0/5

Search a metric to start building a table

Subscribe to unlock 17+ years of financial data, unlimited metrics, transformations, and saved visuals

Start 7-day free trial

Subscribe to unlock 17+ years of data, unlimited metrics, transformations, and saved visuals

Start free trial

Interactive Financial Visualizations

10‑Q10‑K

Stock Price:

OnOff

Transformations:

0/1

Search a metric to start building a visual

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Earnings Market Reaction

10‑Q10‑K

Fiscal Year	Q1 1 Month	Q1 2 Month	Q1 3 Month	Q2 1 Month	Q2 2 Month	Q2 3 Month	Q3 1 Month	Q3 2 Month	Q3 3 Month	Q4 1 Month	Q4 2 Month	Q4 3 Month
2026	-16.70%	-20.34%	-35.34%	-	-	-	-	-	-	-	-	-
2025	10.61%	129.61%	118.44%	-1.41%	15.77%	-56.62%	-15.49%	-38.17%	-28.87%	-12.64%	3.13%	-3.00%
2024	2.56%	-29.24%	-45.58%	36.95%	-17.04%	11.28%	-17.46%	-54.78%	-48.90%	-25.40%	-4.23%	28.57%
2023	-	-	-	-	-	-	122.22%	51.11%	154.35%	7.58%	-5.67%	-8.83%
Earnings Market Reaction data beyond 3 years is for subscribers only. Unlock the full earnings market reaction history Start 7-day free trial

Subscribe to unlock 17+ years of financial data and 90+ calculated metrics

Start 7-day free trial

Subscribe to unlock 17+ years of data and 90+ calculated metrics

Start free trial

Performance and Valuation Metrics

Rows marked with a lock icon are subscribers only — subscribe to unlock 90+ calculated metrics and 17+ years of history.

Metrics	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30	2024-03-31	2023-12-31	2023-09-30
Liquidity Ratios
Current Ratio	0.95	1.78	3.30	4.77	6.09	11.85	16.32	14.19	6.07	5.99	0.84	1.11
Quick Ratio	0.91	1.67	3.24	4.33	5.93	11.74	16.28	14.07	6.00	5.94	0.82	1.10
Working Capital	-572.22K	8.16M	18.89M	31.56M	42.27M	57.71M	66.49M	74.18M	72.68M	78.77M	-2.25M	1.57M
Leverage & Debt
Debt to Equity	-23.19	1.15	0.41	0.26	0.19	0.09	0.07	0.08	0.20	0.20	-6.60	8.20
Interest Coverage TTM	-7,467.01	-16,181.42	-20,028.78	-1,115.12	-328.02	-60.76	-29.47	-16.77	-27.29	-28.52	-38.33	-75.96
Debt Ratio	1.05	0.54	0.29	0.21	0.16	0.09	0.06	0.07	0.17	0.17	1.18	0.89
Efficiency & Turnover
Asset Turnover TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Per Share Metrics
Diluted EPS TTM	-1.27	-1.44	-1.41	-1.29	-1.07	-0.82	-0.73	-0.55	-1.09	-1.34	-5.37	-5.47
Free Cash Flow Per Share TTM	-0.98	-1.07	-1.09	-1.05	-0.88	-0.79	-0.74	-0.58	-0.51	-0.52	-1.99	-1.90
Dividend Per Share TTM	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Growth Metrics
Net Income Growth (1Y)	19.16%	75.59%	110.50%	141.19%	0.20%	-12.92%	-29.43%	-50.74%	98.55%	73.55%	93.23%	256.25%
EPS Growth (1Y)	19.06%	75.46%	93.65%	136.04%	-2.30%	-38.51%	-86.45%	-90.00%	-80.05%	-76.65%	-38.74%	-10.32%
Valuation Metrics
P/E TTM	-0.55	-0.43	-0.53	-3.04	-3.91	-1.93	-3.89	-7.15	-7.32	-11.68	-0.51	-0.75
P/B TTM	-55.34	2.71	1.48	4.75	3.80	1.06	1.52	2.00	4.25	5.55	-8.94	19.01
Market Cap	27.52M	24.39M	29.74M	155.89M	165.78M	63.05M	103.26M	151.78M	309.74M	437.92M	19.06M	32.23M
Enterprise Value	19.59M	16.49M	23.85M	137.45M	141.94M	16.63M	34.84M	75.29M	231.40M	350.10M	13.09M	22.19M
Calculated Values
Free Cash Flow TTM	-38.81M	-42.43M	-43.07M	-41.53M	-34.94M	-31.32M	-26.84M	-22.47M	-19.75M	-14.61M	-13.96M	-15.00M
Net Debt	-7.93M	-7.90M	-5.88M	-18.44M	-23.84M	-46.42M	-68.42M	-76.49M	-78.34M	-87.81M	-5.96M	-10.04M
Per-Share and Margin
EPS TTM
Adjusted EPS TTM
Cash Flow Per Share TTM
Pretax Margin TTM
Stock Comp to Revenue TTM
Turnover Ratios and Averages
Average Assets
Average Equity
Average Inventory
Average Receivables
Average Accounts Payables
Inventory Turnover TTM
Payables Turnover TTM
Days Inventory Outstanding TTM
Days Payables Outstanding TTM
Cash Conversion Cycle TTM
Working Capital to Revenue
Deferred Revenue to Revenue
Growth Rates
Total Assets Growth (1Y)
Total Assets Growth (3Y)
Total Assets Growth (5Y)
Dividends Paid Growth (1Y)
Dividends Paid Growth (3Y)
Dividends Paid Growth (5Y)
EPS Growth (3Y)
EPS Growth (5Y)
Net Income Growth (3Y)
Net Income Growth (5Y)
Net Profit Margin Growth (1Y)
Net Profit Margin Growth (3Y)
Net Profit Margin Growth (5Y)
Net Revenue Growth (3Y)
Net Revenue Growth (5Y)
Deferred Revenue Growth (1Y)
Retained Earnings Growth (1Y)
Credit, Liquidity, Returns, Payout
Cash Ratio
Net Working Capital
Debt to EBITDA TTM
Net Debt to EBITDA TTM
Net Debt to Equity
Altman A
Altman B
Altman C
Altman D
Altman E
Altman Z-Score
ROA TTM
ROE TTM
NOPAT TTM
ROIC TTM
Effective Tax Rate TTM
Payout Ratio TTM
Dilution Ratio
Retained Earnings to Equity
Treasury Stock to Equity
Treasury Stock Change (1Y)
Accrued to Current Liabilities
NCAV
NCAV Per Share TTM
Valuation Ratios
P/CF TTM
PEG Ratio
Dividend Yield TTM
Free Cash Flow Yield TTM
EV EBITDA TTM
EV EBIT TTM
EV Revenue TTM
EV FCF TTM
Stock Compensation TTM
Adjusted Net Income TTM
Billings TTM
Total Debt
Invested Capital

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Insider Transactions

2025-08-22Sale

Owner: Schwab, Andrew J.

Title: -

Shares: 170,449

Price/Share: $3.42

Value: $582,935.58

Shares Owned: 57,493

Relationship: Director,TenPercentOwner

Ownership: Indirect

2025-08-22Sale

Owner: Rocklage, Scott M, 5Am Ve…

Title: -

Shares: 170,449

Price/Share: $3.42

Value: $582,935.58

Shares Owned: 57,493

Relationship: TenPercentOwner

Ownership: Indirect

2024-11-18Sale

Owner: Diep, Tuan Tu

Title: Chief Development Officer

Shares: 19,489

Price/Share: $4.99

Value: $97,250.11

Shares Owned: 82,259

Relationship: Officer

Ownership: Direct

2024-11-18Sale

Owner: Dhillon, Punit

Title: Chief Executive Officer

Shares: 82,546

Price/Share: $4.99

Value: $411,904.54

Shares Owned: 329,823

Relationship: Director,Officer

Ownership: Direct

2024-11-18Sale

Owner: Grayson, Paul A.

Title: -

Shares: 86,244

Price/Share: $4.99

Value: $430,357.56

Shares Owned: 259,701

Relationship: Director

Ownership: Direct

Filed Date	Owner	Relationship	Title	Ownership	Purchase/Sale	No. Shares	Price Per Share	Value	Shares Owned	Document Type
2025-08-22	Schwab, Andrew J.	Director,TenPercentOwner	-	Indirect	Sale	170,449	3.42	$582,935.58	57,493	4
2025-08-22	Rocklage, Scott M, 5Am Ve…	TenPercentOwner	-	Indirect	Sale	170,449	3.42	$582,935.58	57,493	4
2024-11-18	Diep, Tuan Tu	Officer	Chief Development Officer	Direct	Sale	19,489	4.99	$97,250.11	82,259	4
2024-11-18	Dhillon, Punit	Director,Officer	Chief Executive Officer	Direct	Sale	82,546	4.99	$411,904.54	329,823	4
2024-11-18	Grayson, Paul A.	Director	-	Direct	Sale	86,244	4.99	$430,357.56	259,701	4
2024-11-18	Arsenault, Kaitlyn	Officer	Chief Financial Officer	Direct	Sale	43,206	4.99	$215,597.94	166,342	4
2024-11-18	Arsenault, Kaitlyn	Officer	Chief Financial Officer	Direct	Sale	43,026	4.99	$214,699.74	167,522	4/A
2024-09-13	5Am, Ventures Vii, L.P., …	TenPercentOwner	-	Indirect	Sale	13,837	6.06	$83,852.22	66,277	4
2024-09-13	Schwab, Andrew J.	Director,TenPercentOwner	-	Indirect	Sale	13,837	6.06	$83,852.22	66,277	4
2024-03-13	Parmar, Kush, 5Am Partner…	TenPercentOwner	-	Indirect	Purchase	450,000	10.00	$4,500,000.00	8,393,520	4
2024-01-31	Diekman, John D, Parmar K…	TenPercentOwner	-	Indirect	Purchase	5,206,074	2.31	$12,026,030.94	7,943,520	4
2023-08-29	Dhillon, Punit	Director,Officer	Chief Executive Officer	Direct	Purchase	881,000	0.02	$17,620.00	25,683,957	4/A
Additional insider transactions are for subscribers only. Unlock the complete Form 4 filing history Start 7-day free trial

Subscribe to unlock 17+ years of financial data

Start 7-day free trial

Subscribe to unlock 17+ years of data

Start free trial

Institutional Ownership

No data available for chart

2026-03-31

40.65%

Inst. Shares: 16,129,853

Shares Outstanding: 39,681,465

2025-12-31

40.55%

Inst. Shares: 16,081,491

Shares Outstanding: 39,662,664

2025-09-30

50.13%

Inst. Shares: 19,883,162

Shares Outstanding: 39,665,927

2025-06-30

51.38%

Inst. Shares: 20,375,867

Shares Outstanding: 39,659,266

2025-03-31

62.17%

Inst. Shares: 24,652,742

Shares Outstanding: 39,651,888

Date	Institutional Shares Owned	Shares Outstanding	Institutional Ownership %
2026-03-31	16,129,853	39,681,465	40.65%
2025-12-31	16,081,491	39,662,664	40.55%
2025-09-30	19,883,162	39,665,927	50.13%
2025-06-30	20,375,867	39,659,266	51.38%
2025-03-31	24,652,742	39,651,888	62.17%
2024-12-31	25,114,252	36,486,519	68.83%
2024-09-30	25,632,985	38,819,387	66.03%
2024-06-30	24,440,056	38,669,330	63.20%
2024-03-31	2,009,302	27,999,901	7.18%
Additional institutional holders are for subscribers only. Unlock the complete Form 13F ownership history Start 7-day free trial

Skye Bioscience, Inc. (SKYE) — SEC Financial Statements & Analysis

Skye Bioscience, Inc. (SKYE) is a pharmaceutical preparations company, incorporated in NV. Skye Bioscience, Inc. trades on Nasdaq as: SKYE. Based on its latest SEC filing (Form 10-Q, period ending 2026-06-30), Skye Bioscience, Inc. reported a Debt-to-Equity ratio of -23.19x, a Price-to-Book (P/B) ratio of -55.34x (TTM), at a market cap of $27.52M. Figures below are sourced from SEC EDGAR, as-filed.

Debt To Equity: -23.19x
P/B TTM: -55.34x
Market Cap: $27.52M

Data as of 2026-06-30 · Source: SEC EDGAR

Frequently Asked Questions

What industry is Skye Bioscience, Inc. in?

Skye Bioscience, Inc. (SKYE) operates in the Pharmaceutical Preparations industry.

What is SKYE's market cap?

Skye Bioscience, Inc. (SKYE) has a market capitalization of $27.52M as of 2026-06-30.

What exchange does SKYE trade on?

Skye Bioscience, Inc. (SKYE) trades on the Nasdaq.

Where is Skye Bioscience, Inc. incorporated?

Skye Bioscience, Inc. is incorporated in NV.